© 2023 MJH Life Sciences™ and Nutritional Outlook. All rights reserved.
Maypro Group has announced that its proprietary strain of Lactobacillus acidophilus, L-92, is the first ingredient in its portfolio become Non-GMO Project Verified.
Maypro Group (Purchase, NY) has announced that its proprietary strain of Lactobacillus acidophilus, L-92, is the first ingredient in its portfolio become Non-GMO Project Verified.
“We are really excited to have one of our ingredients become part of the Non-GMO Project Verified portfolio” said Steve Yamada, Maypro Group’s founder and chairman, in a press release. “We hope that we can continue verifying our line of ingredients.”
L-92 is supported by five published double-blind placebo-controlled human clinical studies in both children and adults, and shows promise as a medical food, shown in human clinical studies to help with the dietary management of patients with psoriasis, allergic rhinitis, and cedar pollinosis. These studies have shown that L-92 may soothe and calm irritated skin, reduce redness and swelling, as well as reduce seasonal discomforts.